AKT1 and prostate carcinoma: For example, Li, Xub,c and Ai reported that miR‐495 suppresses cell growth or migration in prostate cancer, endometrial cancer and lung cancer via the down‐regulation of FOXC1 expression or by targeting Akt and mTOR signalling 42, 43, 44, 45.